Ustekinumab is a Safe and Effective Biological Agent for Crohn's Disease in a Liver Transplant Patient

被引：11
|
作者：
Peverelle, Matthew [1 ]
Asadi, Khashayar [2 ]
De Cruz, Peter [1 ,3 ]
机构：
[1] Austin Hlth, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Austin Hlth, Dept Anat Pathol, Melbourne, Vic, Australia
[3] Univ Melbourne, Austin Acad Ctr, Dept Med, Melbourne, Vic, Australia
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷 / 10期
关键词：
Ustekinumab; Crohn's disease; liver transplantation; MAINTENANCE THERAPY; INDUCTION;
D O I：
10.1093/ecco-jcc/jjaa062
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1498 / 1499
页数：2
相关论文
共 50 条
  • [1] Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient
    Martinez-Montiel, M.
    Piedracoba-Cadahia, Pilar
    Gomez-Gomez, Carlos
    Gonzalo, J.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (09): : 816 - 817
  • [2] Ustekinumab is safe and effective in pediatric patients with Crohn's disease
    Mitchel, Elana B.
    Dolinger, Michael T.
    Constant, Brad
    Wang, Zi
    Guisado, Daniela
    Gao, Michael
    Fusillo, Steven
    Baldassano, Robert N.
    Kelsen, Judith
    Dubinsky, Marla
    Huang, Jing
    Albenberg, Lindsey
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2025,
  • [3] Biological therapy for Crohn's disease in a liver transplant patient
    Bendezu Garcia, Rogger Alvaro
    Rodriguez Manrique, Marco Antonio
    Hernandez Martinez, Alvaro
    Lazaro Saez, Marta
    Patron Roman, Gustavo Oliver
    Amat Alcaraz, Sergio
    Vega Saenz, Jose Luis
    JOURNAL OF DIGESTIVE DISEASES, 2013, 14 (10) : 564 - 566
  • [4] Ustekinumab Is Safe, but Less Effective in Elderly Crohn's Disease Patients
    Garg, Rajat
    Aggarwal, Manik
    Achkar, Jean P.
    Lashner, Bret
    Philpott, Jessica
    Cohen, Benjamin
    Rieder, Florian
    Qazi, Taha
    Regueiro, Miguel
    Click, Benjamin H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S398 - S399
  • [5] Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn’s Disease Patients
    Gerum Gashaw Gebeyehu
    Joseph Fiske
    Eleanor Liu
    Jimmy K. Limdi
    Giacomo Broglio
    Christian Selinger
    Violeta Razsanskaite
    Philip J. Smith
    Paul K. Flanagan
    Sreedhar Subramanian
    Digestive Diseases and Sciences, 2023, 68 : 1983 - 1994
  • [6] Ustekinumab and Vedolizumab Are Equally Safe and Effective in Elderly Crohn's Disease Patients
    Gebeyehu, Gerum Gashaw
    Fiske, Joseph
    Liu, Eleanor
    Limdi, Jimmy K.
    Broglio, Giacomo
    Selinger, Christian
    Razsanskaite, Violeta
    Smith, Philip J.
    Flanagan, Paul K.
    Subramanian, Sreedhar
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (05) : 1983 - 1994
  • [7] USTEKINUMAB IS SAFE IN ELDERLY CROHN'S DISEASE PATIENTS
    Garg, Rajat
    Aggarwal, Manik
    Regueiro, Miguel D.
    Click, Benjamin H.
    GASTROENTEROLOGY, 2020, 158 (06) : S447 - S448
  • [8] Ustekinumab as an Induction Agent for Crohn's Disease of the Pouch
    Singh, Amandeep
    Ghouri, Yezaz
    Shen, Bo
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (05) : E12 - E13
  • [9] Ustekinumab as the First Biological Agent for Crohn's Disease in a 10-Year-Old Girl
    Fujita, Yuji
    Sugaya, Takeshi
    Tanaka, Takanao
    Tominaga, Keiichi
    Yoshihara, Shigemi
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 255 (01): : 57 - 60
  • [10] A Drug Reaction to Ustekinumab in a Patient With Crohn's Disease
    Yabumoto, Maya
    Wong, Kimberly
    Parekh, Nimisha
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1202 - S1202
12345